share_log

Goldman Sachs Maintains Neutral on LifeStance Health Gr, Lowers Price Target to $8

Benzinga ·  Nov 22, 2023 09:22

Goldman Sachs analyst Jamie Perse maintains LifeStance Health Gr (NASDAQ:LFST) with a Neutral and lowers the price target from $9 to $8.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment